Federal auditors are looking into whether the Orphan Drug Act still serves its intended purpose and whether drugmakers may be abusing its incentives to maximize profits.
As the CMS works to remove Social Security numbers from millions of Medicare ID cards, providers are calling on the agency to increase physician outreach efforts to alert them how billing under the program may change.
It's unclear whether congressional leaders will fully consider the alternative Medicaid reform plan proposed by four Republican governors from expansion states, especially given that they want the House to vote on the GOP bill later this week and the Senate to pass it soon after.
Fleming will serve as deputy assistant secretary for health technology at HHS.
Sanford Health sued the U.S. government to recoup unpaid payments under the ACA's risk-corridor program, but it's looking less and less likely that the feds will ever pay up.
PBMs and tech startups are responding to underinsurance and the onslaught of high-deductible health plans by cutting out insurers in the quest to help patients lower their prescription drug costs.
Ascension will sell St. Joseph Regional Medical Center in Lewiston, Idaho, to for-profit hospital chain RCCH Healthcare Partners.
When Judge Neil Gorsuch interviewed to be appointed to the U.S. Supreme Court, he was never asked to promise he would overturn abortion rights protection under Roe v. Wade, the prospective justice said Tuesday.
For now, it's a delay of three months, but the CMS is considering pushing back the Comprehensive Care for Joint Replacement program and its cardiac bundles until 2018.
The GOP plan to overhaul Medicaid as part of the Affordable Care Act replacement could affect more than 11 million beneficiaries who are also covered by Medicare.
House conservatives and outside experts doubt HHS Secretary Tom Price has legal authority to substantially revise the Affordable Care Act's key insurance market regulations and other provisions by issuing new rules and guidance.
U.S. Supreme Court nominee Neil Gorsuch faced scrutiny Monday from Senate Democrats over his stances on several healthcare issues including contraception access and abortion rights.